JUVENILE DERMATOMYOSITIS
Clinical trials for JUVENILE DERMATOMYOSITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE DERMATOMYOSITIS trials appear
Sign up with your email to follow new studies for JUVENILE DERMATOMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare muscle disease: experimental drug trial shows promise
Disease control CompletedThis study tested whether adding the drug baricitinib to standard steroid treatment works better for children newly diagnosed with juvenile dermatomyositis, a rare and serious autoimmune disease that causes muscle weakness and skin rashes. Sixteen children aged 3-18 participated …
Matched conditions: JUVENILE DERMATOMYOSITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Coaching program aims to bridge gap for young adults leaving pediatric arthritis care
Disease control CompletedThis study tested whether a coaching program is practical and acceptable for young adults with childhood-onset arthritis (like juvenile idiopathic arthritis or lupus) as they move from pediatric to adult rheumatology care. The program aimed to provide support and teach self-manag…
Matched conditions: JUVENILE DERMATOMYOSITIS
Phase: NA • Sponsor: McMaster University • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC